Sativex is the only approved cannabis-based medicine registered with Pharmac, but is not funded. It can be prescribed by a doctor but each case needs Ministry of Health approval. To date, there have been 97 ministerial approvals, and there are currently 27 users of Sativex. Each bottle lasts around four weeks and costs $1050. The Jeffries paid for the first script with a well-timed tax return and have set up a Givealittle page to help fund repeat scripts.
"[Zoe] is a lot more settled overall, she definitely is having less spasms. We are definitely seeing positives, seeing her more relaxed. [At school] she was more settled and not freaking out with all the noises and was able to cope longer in a classroom setting."
Mrs Jeffries said they remained "cautiously optimistic" but realised it wasn't a cure-all for Zoe's condition.
"We just want to give her a better quality of life. We have glimpses of Zoe's personality come through all the drugs that is suppressing what's underneath. This gives us hope, I guess. We don't have all our eggs in this one basket but we do hope. We want to have no regrets and that we have tried everything."
Mrs Jeffries is a trustee of United in Compassion NZ, a trust who aimed to educate New Zealanders on the potential therapeutic benefits of medical cannabis as well as facilitating New Zealand-based research.
Chief executive Toni-Marie Matich said they had been working constructively with Mr Dunne who had tasked her with a working group within the Ministry of Health on this issue.
"I am meeting with the minister to discuss our initiatives which we do regularly and will be discussing if a submission can be made to Pharmac or presented by our organisation."
United in Compassion NZ will host a national symposium of international experts next year in Wellington.
-Zoe's Sativex Givealittle page: https://givealittle.co.nz/cause/medsforzoe/
- Additional reporting, Herald on Sunday.